Founder and Chairman: Dr. Liu Mi, graduated with a master's degree from the School of Pharmacy at Peking University in 2010, a doctoral degree from the Department of Pharmacy at ETH Z ü rich in Zurich in 2014, and a postdoctoral fellow in the Department of Immunology at Harvard Medical School in November 2014. Joined the Pharmacy Department of Suzhou University School of Pharmacy as a distinguished professor and doctoral supervisor in December 2018. It is mainly engaged in research on preventive and therapeutic cancer vaccines, therapeutic neutralizing antibodies against COVID-19, mRNA vaccines, immune multi target detection technologies, etc. He has published many papers in Nature Communications, Advanced Materials, Advanced Functional Materials, Progress in Polymer Science and other international outstanding journals as a corresponding author or the first author, and has applied for more than 20 international patents and domestic patents on neutralizing antibodies against COVID-19, preventive and therapeutic cancer vaccines, immune multi target detection technology and other international patents.
